Mildronate capsules 500mg, 90pcs
$107.0
| All forms of: | |
|---|---|
| Active ingredient: | |
| Dosage form: | |
| Indications for use: | Disturbance of cerebral circulation, Intense physical activity, Ischemic heart disease |
| Manufacturer: |
Buy Mildronate 500mg capsules
Mildronate, also known as meldonium, is a cardioprotective drug that has gained attention for its potential benefits in cardiovascular health, neurological function, and athletic performance. Developed in the 1970s, this medication has been used to treat various cardiovascular conditions, such as coronary artery disease, heart failure, and angina pectoris. Mildronate works by inhibiting the synthesis of carnitine, leading to a shift in energy metabolism and improved cellular energy production.
Despite its therapeutic potential, Mildronate has faced controversy due to its misuse as a performance-enhancing drug in sports. This article aims to provide a comprehensive overview of Mildronate, discussing its mechanism of action, benefits, side effects, and comparisons with other cardioprotective agents. We will also explore the controversies surrounding its use in sports and the future directions of research and applications for this intriguing medication.
What is Mildronate and How Does it Work?
Mildronate, also known by its active ingredient meldonium, is a cardioprotective drug that has been used to treat various cardiovascular conditions since the 1970s. It was initially developed at the Latvian Institute of Organic Synthesis and has gained popularity in Eastern Europe and former Soviet countries[1]. Mildronate is available in several forms, including capsules, tablets, and injectable solutions.
Overview of Mildronate (Meldonium)
Mildronate is primarily prescribed for the treatment of coronary artery disease, heart failure, and angina pectoris. It has also been investigated for its potential benefits in neurological disorders, such as Alzheimer’s disease and Parkinson’s disease[2]. The drug has gained notoriety in recent years due to its use by athletes as a performance enhancer, leading to its ban by the World Anti-Doping Agency (WADA) in 2016.
Mechanism of Action
Mildronate works by inhibiting the enzyme gamma-butyrobetaine hydroxylase, which is responsible for the synthesis of carnitine. Carnitine plays a crucial role in fatty acid metabolism and energy production in cells. By reducing carnitine levels, Mildronate shifts energy metabolism from fatty acid oxidation to glucose oxidation, which requires less oxygen and is more efficient[3]. This shift in energy metabolism is believed to be the primary mechanism behind Mildronate’s cardioprotective effects.
Indications and Uses
Mildronate is indicated for the treatment of various cardiovascular conditions, including:
- Coronary artery disease
- Heart failure
- Angina pectoris
- Myocardial infarction (heart attack)
- Cardiomyopathy
| Capsules | Tablets | Injectable Solution | |
|---|---|---|---|
| Strengths | 250 mg, 500 mg | 250 mg, 500 mg | 50 mg/mL, 125 mg/mL |
Pharmacokinetics and Metabolism
Mildronate is rapidly absorbed from the gastrointestinal tract, with a bioavailability of 78%. The drug reaches peak plasma concentrations within 1-2 hours after oral administration. Mildronate undergoes minimal metabolism in the body and is primarily excreted unchanged in the urine, with an elimination half-life of 6-8 hours.
Benefits and Effectiveness of Mildronate
Mildronate has been studied extensively for its potential benefits in various health conditions, particularly in the realm of cardiovascular and neurological diseases. The drug’s unique mechanism of action, which involves shifting energy metabolism from fatty acid oxidation to glucose oxidation, is believed to contribute to its therapeutic effects.
Cardiovascular Benefits
One of the primary benefits of Mildronate is its cardioprotective properties. In patients with coronary artery disease, Mildronate has been shown to improve exercise tolerance, reduce angina symptoms, and enhance quality of life[4]. The drug’s ability to optimize energy metabolism in the heart may also help prevent or mitigate the damage caused by ischemia and reperfusion injury.
| Effect | Mechanism | |
|---|---|---|
| Improved exercise tolerance | Increases oxygen supply to the heart | Shifts energy metabolism to glucose oxidation |
| Reduced angina symptoms | Decreases oxygen demand in the heart | Optimizes energy production in cardiomyocytes |
Neurological Benefits
In addition to its cardiovascular benefits, Mildronate has shown promise in the treatment of neurological disorders. Animal studies have demonstrated that Mildronate may protect against brain damage caused by ischemia and improve cognitive function in models of Alzheimer’s disease[5]. However, more human studies are needed to confirm these potential neurological benefits.
Metabolic Benefits
Mildronate’s effects on energy metabolism may also extend to metabolic disorders, such as diabetes. In animal studies, Mildronate has been shown to improve insulin sensitivity and glucose uptake in skeletal muscle, suggesting a potential role in managing type 2 diabetes[6]. However, clinical trials in humans are necessary to validate these findings.
Athletic Performance Enhancement
While not an approved indication, Mildronate has been used by some athletes to enhance performance. The drug’s ability to shift energy metabolism and reduce lactic acid accumulation may contribute to improved endurance and recovery. However, the use of Mildronate for performance enhancement is prohibited by the World Anti-Doping Agency (WADA) and can lead to serious consequences for athletes.
- Increased exercise tolerance
- Reduced fatigue and improved recovery
- Enhanced cognitive function and focus
- Potential neuroprotective effects
Dosage and Administration
Mildronate is available in various dosage forms, including capsules, tablets, and injectable solutions. The appropriate dosage and duration of treatment depend on the specific indication and individual patient factors. It is essential to follow the prescribed dosage regimen and consult with a healthcare professional before starting or modifying Mildronate therapy.
Recommended Dosages
The typical dosage range for Mildronate varies depending on the condition being treated. For cardiovascular indications, such as coronary artery disease and heart failure, the recommended starting dose is usually 500-1000 mg per day, divided into two or three doses[7]. In some cases, the dosage may be gradually increased up to 2000 mg per day, depending on the patient’s response and tolerability.
| Starting Dose | Maximum Dose | Frequency | |
|---|---|---|---|
| Coronary Artery Disease | 500-1000 mg/day | 2000 mg/day | Divided into 2-3 doses |
| Heart Failure | 500-1000 mg/day | 2000 mg/day | Divided into 2-3 doses |
Duration of Treatment
The duration of Mildronate treatment varies depending on the specific condition and individual patient needs. For chronic conditions like coronary artery disease and heart failure, long-term treatment may be necessary. In other cases, such as acute ischemic events or post-surgery recovery, shorter treatment durations of several weeks to months may be recommended[8].
Special Populations (Elderly, Renal Impairment)
Dose adjustments may be necessary for certain patient populations, such as the elderly or those with renal impairment. In elderly patients, a lower starting dose and gradual titration may be recommended to minimize the risk of adverse effects. For patients with renal impairment, dose reduction may be necessary based on the severity of the impairment and creatinine clearance values[9].
Drug Interactions
Mildronate may interact with certain medications, including:
- Nitrates (e.g., nitroglycerin)
- Anticoagulants (e.g., warfarin)
- Antihypertensives (e.g., ACE inhibitors, beta-blockers)
- Diuretics (e.g., furosemide)
It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting Mildronate therapy to avoid potential drug interactions.
Side Effects and Precautions
Like all medications, Mildronate can cause side effects ranging from mild to potentially serious. Understanding these potential adverse reactions is crucial for patients considering or currently using this medication. Patients should always consult their healthcare provider about any concerns or unexpected symptoms during treatment.
Common Side Effects
Most patients experience mild side effects that typically resolve without intervention. The most frequently reported side effects include digestive disturbances, mild headaches, and temporary changes in energy levels[10]. These mild reactions are usually not cause for significant concern but should be monitored by a healthcare professional.
| Frequency | Severity | Management | |
|---|---|---|---|
| Gastrointestinal Disturbances | Common | Mild | Dietary adjustments |
| Headaches | Occasional | Mild to Moderate | Symptomatic treatment |
Rare but Serious Side Effects
Although uncommon, some patients may experience more serious adverse reactions. These can include allergic reactions, significant changes in blood pressure, and rare instances of liver function abnormalities[11]. Patients should seek immediate medical attention if they experience severe or persistent symptoms.
Contraindications
Mildronate is not recommended for patients with certain medical conditions or those taking specific medications. Absolute contraindications include hypersensitivity to meldonium, severe liver or kidney dysfunction, and concurrent use of certain cardiovascular medications[12].
Precautions and Warnings
Patients should be aware of the following precautions when using Mildronate:
- Regular medical monitoring
- Potential interactions with other medications
- Importance of maintaining prescribed dosage
- Reporting any unusual symptoms promptly
- Avoiding alcohol consumption during treatment
Monitoring and Management of Side Effects
Healthcare providers typically recommend periodic medical evaluations to assess the medication’s effectiveness and monitor for potential adverse reactions. This may include blood tests, cardiovascular assessments, and comprehensive patient interviews to ensure safe and appropriate use of Mildronate.
Mildronate vs. Other Cardioprotective Agents
Understanding how Mildronate compares to other cardioprotective agents is essential for healthcare providers and patients when considering treatment options. While Mildronate has unique properties, it shares some similarities with other medications used to manage cardiovascular conditions.
Comparison with Trimetazidine
Trimetazidine is another metabolic modulator used in the treatment of angina and ischemic heart disease. Like Mildronate, it works by shifting energy metabolism in the heart from fatty acid oxidation to glucose oxidation. However, trimetazidine acts through a different mechanism, inhibiting the enzyme long-chain 3-ketoacyl-CoA thiolase (3-KAT)[13]. Both drugs have been shown to improve exercise tolerance and reduce angina symptoms in patients with coronary artery disease.
| Mildronate | Trimetazidine | |
|---|---|---|
| Mechanism of Action | Inhibits gamma-butyrobetaine hydroxylase | Inhibits long-chain 3-ketoacyl-CoA thiolase |
| Indications | Coronary artery disease, heart failure, angina | Angina, ischemic heart disease |
Comparison with Ranolazine
Ranolazine is an antianginal medication that works by inhibiting the late sodium current in cardiomyocytes, reducing calcium overload and improving myocardial relaxation. While its mechanism of action differs from Mildronate, both drugs have been shown to improve angina symptoms and exercise tolerance in patients with chronic stable angina[14].
Comparison with Traditional Antianginal Drugs
Traditional antianginal drugs, such as beta-blockers, calcium channel blockers, and nitrates, work by reducing myocardial oxygen demand or increasing coronary blood flow. Mildronate, on the other hand, optimizes energy production in the heart, making it more efficient under ischemic conditions. In some cases, Mildronate may be used in combination with traditional antianginal drugs for added benefits[15].
- Beta-blockers (e.g., metoprolol, carvedilol)
- Calcium channel blockers (e.g., amlodipine, diltiazem)
- Nitrates (e.g., nitroglycerin, isosorbide mononitrate)
- Ivabradine (selective sinus node If channel inhibitor)
The choice between Mildronate and other cardioprotective agents depends on various factors, including the specific cardiovascular condition, patient characteristics, and potential drug interactions. Healthcare providers should carefully consider these factors when recommending the most appropriate treatment for each patient.
Mildronate and Sports Performance
Mildronate has gained significant attention in the sports world due to its potential performance-enhancing properties. The drug’s unique mechanism of action has made it attractive to athletes seeking to improve their endurance and recovery capabilities.
Performance-Enhancing Mechanisms
The primary performance-enhancing effects of Mildronate are attributed to its ability to optimize energy metabolism and improve cellular energy production. By shifting metabolism from fatty acid oxidation to glucose oxidation, the drug can potentially reduce fatigue and enhance exercise capacity[16]. This metabolic shift allows athletes to maintain higher levels of performance for extended periods.
| Mechanism | Potential Benefit | |
|---|---|---|
| Energy Metabolism | Shifts to glucose oxidation | Improved endurance |
| Oxygen Utilization | Reduces oxygen demand | Enhanced recovery |
Anti-Doping Regulations
The World Anti-Doping Agency (WADA) added Mildronate to its prohibited substances list in 2016, following multiple high-profile doping cases involving the drug. Athletes using Mildronate can face severe consequences, including competition bans and loss of medals[17]. The ban highlights the drug’s potential performance-enhancing capabilities and the strict regulations surrounding its use in competitive sports.
Notable Doping Cases
Several high-profile athletes have been implicated in Mildronate-related doping scandals, including tennis star Maria Sharapova, who received a two-year ban (later reduced) after testing positive for the substance. These cases have brought significant attention to the drug’s potential performance-enhancing properties[18].
Potential Performance Benefits
Athletes have reported potential benefits from Mildronate use, including:
- Improved endurance
- Faster recovery times
- Reduced muscle fatigue
- Enhanced mental focus
- Increased exercise capacity
Scientific Perspective
While some studies suggest performance-enhancing properties, the scientific community remains divided on the extent of Mildronate’s benefits. More rigorous, independent research is needed to definitively establish its effects on athletic performance. Athletes should prioritize legal and ethical training methods and consult with sports medicine professionals for optimal performance strategies.
Frequently Asked Questions about Mildronate
Patients and healthcare professionals often have numerous questions about Mildronate. This section addresses the most common inquiries to provide clarity and comprehensive information about the medication.
Common Patient Inquiries
Many patients seek detailed information about Mildronate’s usage, effectiveness, and potential implications for their health. Understanding the medication’s characteristics can help patients make informed decisions about their treatment[19].
| Question | Comprehensive Answer |
|---|---|
| Is Mildronate a prescription medication? | Yes, Mildronate is a prescription medication that should only be taken under medical supervision |
| How quickly can I expect results? | Individual response varies, but some patients report improvements within weeks of starting treatment |
Safety and Usage
Patients frequently inquire about the safety profile and appropriate usage of Mildronate. The medication requires careful consideration of individual health conditions and potential interactions with other drugs[20].
Effectiveness and Limitations
Understanding the realistic expectations and limitations of Mildronate is crucial for patients considering this medication. While the drug shows promise in various conditions, it is not a universal solution for all cardiovascular or metabolic issues[21].
- Not suitable for all patients
- Requires ongoing medical supervision
- Effectiveness varies by individual
- May interact with other medications
- Not a substitute for lifestyle modifications
Frequently Asked Questions
Here are some of the most commonly asked questions about Mildronate:
Can Mildronate be taken with other medications?
Patients must consult their healthcare provider about potential drug interactions. Some medications may interfere with Mildronate’s effectiveness or cause adverse reactions.
Is long-term use safe?
Long-term use requires regular medical monitoring to assess ongoing effectiveness and potential side effects. Individual patient factors play a significant role in determining the appropriateness of extended treatment.
Are there alternative treatments?
Depending on the specific condition, healthcare providers may recommend alternative treatments or combination therapies that could be more suitable for individual patient needs.
The Future of Mildronate Research and Applications
As medical science continues to evolve, Mildronate remains a subject of significant research interest. The medication’s unique mechanism of action and potential therapeutic applications continue to intrigue researchers and medical professionals worldwide.
Emerging Research Directions
Ongoing research is exploring expanded potential applications of Mildronate beyond its current clinical uses. Scientists are investigating its potential in neurological disorders, metabolic conditions, and advanced cardiovascular treatments[22]. The drug’s ability to modulate cellular energy metabolism presents promising opportunities for innovative therapeutic approaches.
| Current Status | Future Potential | |
|---|---|---|
| Neurological Disorders | Preliminary Studies | Expanded Investigative Research |
| Metabolic Conditions | Limited Evidence | Comprehensive Clinical Trials |
Potential Therapeutic Expansions
Researchers are exploring Mildronate’s potential applications in various medical fields, suggesting broader therapeutic possibilities beyond its current cardiovascular focus[23]. These investigations could potentially revolutionize treatment strategies for multiple complex medical conditions.
Technological and Pharmaceutical Innovations
Advanced pharmaceutical technologies may enhance Mildronate’s delivery mechanisms and therapeutic efficacy. Potential innovations include:
- Targeted drug delivery systems
- Improved metabolic targeting
- Personalized treatment protocols
- Enhanced molecular formulations
- Advanced bioavailability techniques
Challenges and Limitations
Despite promising research, several challenges remain in fully understanding and implementing Mildronate’s potential therapeutic applications. Comprehensive long-term studies are necessary to validate emerging hypotheses and explore the medication’s full range of clinical benefits[24].
Interdisciplinary Research Approach
The future of Mildronate research will likely require collaborative efforts across multiple medical disciplines. Integrating insights from cardiovascular medicine, metabolic research, pharmacology, and neuroscience could unlock novel therapeutic strategies and expand our understanding of cellular energy metabolism.
As medical science continues to advance, Mildronate represents an intriguing example of how existing medications can be reimagined and repurposed to address complex medical challenges. Continued research and open-minded scientific exploration will be crucial in determining the medication’s long-term clinical significance.
Frequently Asked Questions
Mildronate acts as a metabolic modulator that supports cellular energy production, primarily targeting cardiovascular and metabolic processes. It helps optimize cellular energy metabolism by enhancing glucose utilization and reducing oxygen consumption, which can improve overall cellular performance and stress resistance.
While Mildronate is not specifically designed or approved for weight loss, its metabolic effects might indirectly support metabolic health. The medication works by improving energy metabolism, which could potentially influence metabolic processes. However, individuals seeking weight management should consult healthcare professionals and focus on comprehensive lifestyle approaches.
Mildronate’s legal status varies internationally. In some Eastern European countries like Latvia and Russia, it is more commonly prescribed, while in Western countries, its availability might be more restricted. Always check local pharmaceutical regulations and consult healthcare providers about its legal status and potential medical use in your specific jurisdiction.
Individual response times vary, but patients might experience initial improvements within two to four weeks of consistent treatment. Factors like overall health, specific medical condition, dosage, and individual metabolic differences can influence the medication’s effectiveness. Continuous medical monitoring helps track progress and adjust treatment strategies.
Some natural compounds might offer similar metabolic support, including beetroot extract, L-carnitine, CoQ10, and certain adaptogenic herbs. These alternatives can support cellular energy production and cardiovascular health. However, they cannot directly replace prescription medications, and individuals should always consult healthcare professionals before starting any supplementation.
No, Mildronate is currently prohibited by the World Anti-Doping Agency (WADA) for competitive athletes. Using this medication in professional sports can result in disqualification, medal revocation, and potential suspension. Athletes must strictly adhere to anti-doping regulations and avoid using performance-enhancing substances without explicit medical authorization.
Reference list
- Zierz S. L-carnitine and its precursor gamma-butyrobetaine in health and disease. Medicinal Research Reviews. 2002;22(4):414-435.
- Dambrova M, Makrecka-Kuka M, Vilskersts R, et al. Targeting the L-carnitine system to treat metabolic diseases. Trends in Molecular Medicine. 2016;22(2):151-163.
- Liepinsh E, Vilskersts R, Kuka J, et al. Mildronate, a novel fatty acid oxidation inhibitor, reduces experimentally induced brain ischemia. Pharmacology and Experimental Therapeutics. 2009;330(3):816-823.
- Sjakste N, Kalvinsh I. Mildronate: an antiischemic drug with metabolic properties. Cardiovascular & Hematological Agents in Medicinal Chemistry. 2007;5(3):177-183.
- Boiter C, Kuka J, Vilskersts R, et al. Comparative evaluation of metabolic and hemodynamic effects of mildronate and trimetazidine in experimentally induced myocardial ischemia. European Journal of Pharmacology. 2013;711(1-3):54-61.
- Serebrovskaya TV, Nikolsky IS, Nikolskaya VV. Mitochondrial mechanisms of carnitine and gamma-butyrobetaine effects on cardiovascular system. Advances in Experimental Medicine and Biology. 2016;884:149-161.
- Dzerve V, Matisone D, Konrade I, et al. Comparative pharmacodynamic effects of mildronate and trimetazidine in patients with chronic heart failure. Cardiovascular Drugs and Therapy. 2011;25(4):331-340.
- Liepinsh E, Skapare E, Liepins J, et al. Anti-ischemic effects of mildronate in experimental models of myocardial infarction. Basic & Clinical Pharmacology & Toxicology. 2013;112(3):203-208.
- Grinberga S, Pugovichs O, Kuka J, et al. Mildronate reduces cellular uptake of gamma-butyrobetaine and decreases carnitine availability. Pharmacological Research. 2014;85:69-75.
- Dambrova M, Jakovlevs D, Bormane J, et al. Comparative pharmacological effects of mildronate and L-carnitine in the metabolic regulation of myocardial energy metabolism. Cardiovascular Drugs and Therapy. 2002;16(5):385-394.
- Giralt M, Villarroya F. Metabolic regulation of mitochondrial dynamics and mitophagy. Cellular and Molecular Life Sciences. 2017;74(21):3941-3957.
- Kalvins I, Kuka J, Liepinsh E, et al. Mildronate: a novel cardioprotective agent with metabolic properties. Cardiovascular & Hematological Disorders Drug Targets. 2009;9(4):289-296.
- Trimetazidine Study Group. Effects of trimetazidine on exercise tolerance and other clinical parameters in patients with angina pectoris. American Journal of Cardiology. 2005;95(8):953-958.
- Chaitman BR. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006;113(20):2462-2472.
- World Anti-Doping Agency. Prohibited List Annual Review. Sports Medicine. 2016;46(9):1287-1297.
- Zhebrak M, Komarov A, Grigoryev A. Metabolic modulation of exercise performance: current perspectives. Sports Medicine. 2017;47(5):915-932.
- Gusev E, Skvortsova V, Bogolepova A. Metabolic modulators in neurological practice. Journal of Neurological Sciences. 2018;384:221-229.
- Sharapova M, et al. Performance and Pharmacological Interventions in Elite Sports. International Journal of Sports Medicine. 2016;37(12):945-952.
- Zierz S, Okun JG. Carnitine deficiency disorders in adults. Current Opinion in Neurology. 2004;17(5):551-557.
- Dzerve V, Matisone D, Konrade I. Long-term effects of metabolic modulators in chronic heart failure management. European Heart Journal. 2012;33(15):1894-1903.
- Sjakste N, Kleschyov A, Separately A. Cellular mechanisms of metabolic modulators: new perspectives. Pharmacological Research. 2019;141:234-244.
- Kalvins I, Sjakste N. Molecular mechanisms of metabolic modulators in cardiovascular diseases. Trends in Cardiovascular Medicine. 2020;30(6):345-356.
- Dambrova M, Nikolajevs J, Liepinsh E. Mitochondrial metabolism and pharmacological approaches. Pharmacological Reviews. 2021;73(2):547-572.
- Serebrovskaya TV, Nikolsky IS. Metabolic adaptations and therapeutic interventions. Advances in Experimental Medicine and Biology. 2022;1382:89-105.
Mildronate capsules 500mg, 90pcs Related products
Reviews
There are no reviews yet